Long term outcomes in drug resistant tuberculosis with Bedaquiline, Pretomanid and varying doses of Linezolid

Daniel, Bella Devaleenal; Shanmugam, Sivakumar; Mehta, Rashi; Bhalla, Manpreet; Mariappan, Muthuvijayalakshmi; Ramraj, Balaji; Awasthi, Avijit Kumar; Patel, Pranav; Jain, Amita; Jain, Parul; Kumar, Chetan; Oswal, Vikas; Singla, Neeta; Kumar, Santosh; Dave, Jigna; Vadgama, Parul; Bhatnagar, Anuj K; Kant, Surya; Prabhakaran, Rathinam; Tamakuwala, Grinish; Mukherjee, Rishikesh Nath; Santhanakrishnan, Ramesh Kumar; Dhandapani, Ravikumar; Nagarajan, Naveen kumar; Kumaravadivelu, Shanmugapriya; Bharathi, Jeyadeepa; Sridhar, Anand; Ramachandran, Ranjani; Matoo, Sanjay K; Chinnaiyan, Ponnuraja; Jaju, Jyoti; Chandrasekaran, Padmapriyadarsini

research article review

oai:eprints.nirt.res.in:2043

Long term outcomes in drug resistant tuberculosis with Bedaquiline, Pretomanid and varying doses of Linezolid

Abstract

Assess the effectiveness of bedaquiline, pretomanid and linezolid (BPaL) regimens with varying doses and duration of linezolid at the end of 48 weeks post treatment among drug resistant tuberculosis (DR TB) patients

Similar works

Full text

Open in the Core reader

Download PDF

NIRT Institutional Repository

oai:eprints.nirt.res.in:2043

Last time updated on 11/06/2025

This paper was published in NIRT Institutional Repository.

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.